13F-HR filed by Opaleye Management Inc.
Opaleye Management Inc. filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-13, with 36 holding rows worth $197,898,000.
- Accession
- 0001546927-15-000070
- Filer
- CIK 1595855
- Filed
- 2015-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2014
A holdings report, 36 entries on the cover page, a total value of $197,898,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $197,898,000 with VALUE read as thousands by filing date, 13F file number 028-15896. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CHIMERIX INC COM | 16934W106 | Stock | 805,000 | $32,409,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 113,500 | $12,717,000 | thousands by filing date | |
| CEMPRA INC | 15130J109 | COM | 504,800 | $11,868,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 920,000 | $11,261,000 | thousands by filing date | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 1,525,000 | $10,477,000 | thousands by filing date | |
| PHARMACYCLICS INC | 716933106 | COM | 85,000 | $10,392,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 140,000 | $7,840,000 | thousands by filing date | |
| TETRAPHASE PHARMACEUTICALS INC | 88165N105 | COMMON STOCK | 189,700 | $7,533,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 1,825,000 | $5,931,000 | thousands by filing date | |
| VERSARTIS INC | 92529L102 | COM | 235,000 | $5,276,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 191,338 | $5,231,000 | thousands by filing date | |
| INSYS THERAPEUTICS INC | 45824V209 | COMMON STOCK | 122,500 | $5,165,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 106,200 | $4,660,000 | thousands by filing date | |
| GENMARK DIAGNOSTICS INC | 372309104 | COM | 335,000 | $4,559,000 | thousands by filing date | |
| OPHTHOTECH CORP | 683745103 | COM | 100,000 | $4,487,000 | thousands by filing date | |
| KITE PHARMA INC | 49803L109 | COM | 76,000 | $4,383,000 | thousands by filing date | |
| CODEXIS INC | 192005106 | COM | 1,724,000 | $4,344,000 | thousands by filing date | |
| Medgenics Inc New | 58436Q203 | COM NEW | 850,000 | $4,301,000 | thousands by filing date | |
| IMPRIMIS PHARMA IMMY | 45323A201 | COMMON | 560,000 | $4,200,000 | thousands by filing date | |
| ONCOTHYREON INC | 682234108 | COM | 2,000,000 | $3,800,000 | thousands by filing date | |
| CARDIOVASCULAR SYSTEMS INC | 141619106 | COMMON STOCK | 125,000 | $3,760,000 | thousands by filing date | |
| FLAMEL TECHNOLOGIES-SP ADR | 338488109 | SPON | 205,000 | $3,512,000 | thousands by filing date | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 95,000 | $3,204,000 | thousands by filing date | |
| PARATEK PHARMACEUTICALS INC | 699374302 | Equity | 80,000 | $3,084,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 333,333 | $3,000,000 | thousands by filing date | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 350,000 | $2,905,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 975,000 | $2,896,000 | thousands by filing date | |
| HORIZON PHARMA PLC | G4617B105 | SHS | 220,000 | $2,836,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 29,100 | $2,823,000 | thousands by filing date | |
| Accelerate Diagnostics | 00430H102 | COM | 100,000 | $1,919,000 | thousands by filing date | |
| CELGENE CORP | 151020112 | RIGHT 12/31/2030 | 575,000 | $1,811,000 | thousands by filing date | |
| TENAX THERAPEUTICS INC | 88032L100 | COM | 440,000 | $1,690,000 | thousands by filing date | |
| EVOKE PHARMA INC | 30049G104 | COM | 240,000 | $1,416,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 45,000 | $1,005,000 | thousands by filing date | |
| CARA THERAPEUTICS INC | 140755109 | COM | 80,000 | $798,000 | thousands by filing date | |
| BIOLINERX LTD-SPONS ADR | 09071M106 | SPON | 250,000 | $405,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001546927-15-000070 | this filing | 2015-02-13 | acceptance time not in the bulk data set |